← FDA DRUG APPROVALS

FDA NDA · NDA018361

SEROPHENE

Sponsor: EMD SERONO

APPLICATION
NDA018361
TYPE
NDA
ORIGINAL APPROVAL
1982-03-22
LATEST ACTION
2003-07-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SEROPHENEDiscontinued
CLOMIPHENE CITRATE 50MG · TABLET · ORAL

Approval history

2003-07-31Labeling · Supplement 29AP
2002-08-13Labeling · Supplement 28AP
2001-08-14Labeling · Supplement 27AP
2001-02-01Manufacturing (CMC) · Supplement 26AP
1996-04-02Labeling · Supplement 24AP
1994-12-30Manufacturing (CMC) · Supplement 22AP
1985-08-21Manufacturing (CMC) · Supplement 1AP
1982-03-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →